Bladder cancer
Conditions
Interventions
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Age 18-75 2.The patient was pathologically diagnosed as T2 muscular invasive bladder cancer; 3.Imaging examination revealed no lymph node metastasis or distant metastasis of bladder cancer; 4.Organs (heart, liver, lung, kidney) function is basically normal, PS score: 0-2; 5.Bladder capacity >=200ml. 6.Agreeing to comprehensive bladder preservation treatment and can be followed up on time after treatment;
Exclusion criteria
Exclusion criteria: 1.The history of abdominal and pelvic radiation therapy; 2.Metastatic bladder cancer or other cancer involving the bladder; 3.T2 muscular invasive bladder with carcinoma in situ; 4.T2 muscular invasive bladder with neuroendocrine carcinoma; 5.T2 muscular invasive bladder with hydronephrosis; 6.Imaging diagnosis is T2 phase, but pathological diagnosis does not match 7.Those who are allergic to iodine; 8.Pregnant women or lactation patients. 9.Those who researchers believe that it is not suitable to participate in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-free survival in 3 years; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival in 5 years;Disease-specific survival in 5 years;EORTC Quality of Life Questionnaire;Mortality rate in treatment period ;Adverse event occurrence rate; | — |
Countries
China
Contacts
Public ContactLiu Haitao
Shanghai General Hospital
Outcome results
None listed